Shopping Cart
- Remove All
- Your shopping cart is currently empty
Dapivirine (R147681) is a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $44 | In Stock | |
25 mg | $81 | In Stock | |
50 mg | $119 | In Stock | |
100 mg | $173 | In Stock | |
200 mg | $257 | In Stock | |
1 mL x 10 mM (in DMSO) | $30 | In Stock |
Description | Dapivirine (R147681) is a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor. |
Targets&IC50 | HIV RT:24 nM |
In vivo | Dapivirine-containing gel at vaginal level inhibits cell-associated HIV infection in mice. [3] More placebo (7 of 12) than Dapivirine (3 of 24) gel users has positive vaginal swab results, with white blood cells being the most common finding. Dapivirine (0.05%) results in Cmax of 715 pg/mL, AUC of 15 ng×h/mL and T1/2 of 89.87 hours in plasma after 14 days post-dose. Mean Dapivirine (0.05%) concentrations in vaginal fluids collected at the introitus, mid vagina, and cervix are in the range of 62-265 μg/g on day 1. [4] |
Alias | TMC120, R147681 |
Molecular Weight | 329.4 |
Formula | C20H19N5 |
Cas No. | 244767-67-7 |
Smiles | N(C1=C(C)C=C(C)C=C1C)C2=NC(NC3=CC=C(C#N)C=C3)=NC=C2 |
Relative Density. | 1.23g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 32 mg/mL (97.1 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.